BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36502788)

  • 1. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
    Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
    Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
    J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Huang W; Wang Y; Huang W
    Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of fermented tea in MPTP-induced Parkinson's disease mouse model via MAPK signaling-mediated regulation of inflammation and antioxidant activity.
    Lee YR; Moon GH; Shim D; Kim JC; Lee KJ; Chung KH; An JH
    Food Res Int; 2023 Feb; 164():112133. PubMed ID: 36737888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters.
    Kumar S; Awasthi A; Raj K; Singh S
    Psychopharmacology (Berl); 2023 Jul; 240(7):1493-1508. PubMed ID: 37191688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
    Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
    Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the TLR/NF-
    Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
    Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
    Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway.
    Ji M; Niu SQ; Mi HY; Jiang P; Li Y
    Chem Biol Drug Des; 2024 Jan; 103(1):e14358. PubMed ID: 37749299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease.
    Huang YL; Zhang JN; Hou TZ; Gu L; Yang HM; Zhang H
    Neurochem Int; 2022 Oct; 159():105389. PubMed ID: 35809720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
    Friedemann T; Ying Y; Wang W; Kramer ER; Schumacher U; Fei J; Schröder S
    Am J Chin Med; 2016; 44(5):907-25. PubMed ID: 27430912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.
    Deb S; Dutta A; Phukan BC; Manivasagam T; Justin Thenmozhi A; Bhattacharya P; Paul R; Borah A
    Neurochem Int; 2019 Oct; 129():104478. PubMed ID: 31145971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.